Association of Viraemic Phase Viral Load, Antibody Responses, and Immune Biomarkers With Severe Dengue
Journal of Medical Virology · 2026-04 · 98 (4)
DOI: 10.1002/jmv.70882 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Medical Virology, online erschienen am 27.03.2026. Verfasst von Kalichamy Alagarasu und 28 weiteren Autor:innen. Beteiligte Einrichtung: ICMR-National Institute of Virology, Pune, Maharashtra, India. Hauptthemen laut MEDLINE: Viral Load, Biomarkers, Antibodies, Viral, Dengue Virus. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 36 Literaturangaben.
Abstract (Originalsprache)
Severe dengue is influenced by the virus serotype, viral load, host exposure status, immune response, host genetics, and other host factors. The objective of the present study was to identify a panel of prognostic markers for severe dengue during the viraemic phase. We investigated 326 real‐time RT‐PCR positive dengue cases to find out the association of viral load, antibody titers, and immune status. Plasma levels of 27 cytokines, chemokines, and endothelial cell‐related factors were estimated in a subset of 206 patients. Viral load was lower in DENV‐3 cases compared to DENV‐1 and DENV‐2 cases ( p < 0.0001). Viral load was lower in secondary infections compared to primary infections, irrespective of serotypes ( p < 0.0001). Viral load was not different between dengue patients without warning signs (DWOWS), dengue with warning signs (DWWS), and severe dengue. The total number of cytokines, chemokines, and growth factors produced above the assay detection threshold was higher in severe cases compared to DWOWS and DWWS ( p < 0.05). Penalized multivariate regression identified significant associations between dengue serotype and IgM OD ratio, viral load (log₁₀), granulocyte colony‐stimulating factor, interferon (IFN)‐γ induced protein‐10 (IP‐10), and macrophage inflammatory protein‐1β (MIP‐1β) ( p < 0.05), with good discrimination between DENV‐1 and DENV‐2 infections (area under the curve [AUC] = 81.11%). IgA OD ratio, viral load (log₁₀), interleukin‐10 (IL‐10), MIP‐1α, syndecan‐1 (SDC‐1), and vascular endothelial growth factor‐A were significantly associated with immune status, accurately distinguishing primary and secondary infections (AUC = 92.56%). IFN‐γ, IL‐1β, IL‐1RA, IL‐2, IL‐6, IL‐8, IL‐10, IL‐18, and TPO were significantly elevated in severe dengue cases compared to DWOWS and DWWS ( p < 0.05). Exploratory penalized regression results suggested higher odds of the dengue severity with increasing levels of IgA, IgE, G‐CSF, GM‐CSF, IFN‐α, IFN‐γ, IL‐1β, IL‐1RA, IL‐2, IL‐4, IL‐6, IL‐8, IL‐10, IL‐12p70, IL‐17A, IL‐18, IP‐10, MCP‐1, resistin, SDC‐1, TNF‐α, and VEGF‐D (OR > 1 per standard deviation increase). To conclude, the present study suggests that a dysregulated immune response, indicated by elevated levels of cytokines, chemokines, and endothelial cell‐related factors, occurs in the viraemic phase of severe dengue cases and can be exploited to design a panel of prognostic markers.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- ICMR-National Institute of Virology, Pune, Maharashtra, India.
- Savitribai Phule Pune University, Ganeshkhind, Pune, India.
- Academy of Scientific and Innovative Research (AcSIR), Ghaziabad, India.
- Lilavati Hospital, Mumbai, Maharashtra, India.
- B. J. Government Medical College, Pune, Maharashtra, India.
- Nobel Hospital, Pune, Maharashtra, India.
ORCID-Profile: Kalichamy Alagarasu
Zitieren
APA
Alagarasu, K., Gurav, Y. K., Pulinchani, A., Bachal, R., Bhadale, P., Telmore, A., Kakade, M., Sambhare, S., Sonare, P., Nagvekar, V., Borse, R. T., Dravid, A., Sonali, P., Barsode, S., Pravin, S., Deepali, A., Pandve, H., Kale, N., Shinde, V., …, & Salunkhe, S. (2026). Association of Viraemic Phase Viral Load, Antibody Responses, and Immune Biomarkers With Severe Dengue. Journal of Medical Virology, 98(4). https://doi.org/10.1002/jmv.70882
Vancouver
Alagarasu K, Gurav YK, Pulinchani A, Bachal R, Bhadale P, Telmore A, et al. Association of Viraemic Phase Viral Load, Antibody Responses, and Immune Biomarkers With Severe Dengue. Journal of Medical Virology. 2026;98(4). doi:10.1002/jmv.70882
BibTeX
@article{Alagarasu2026,
author = {Alagarasu, Kalichamy and Gurav, Yogesh K and Pulinchani, Anisha and Bachal, Rupali and Bhadale, Pradnya and Telmore, Aishwarya and Kakade, Mahadeo and Sambhare, Susmit and Sonare, Pratiksha and Nagvekar, Vasant and Borse, R T and Dravid, Ameet and Sonali, Palkar and Barsode, Supriya and Pravin, Soni and Deepali, Ambike and Pandve, Harshal and Kale, Narendra and Shinde, Varsha and Mane, Shailaja and Kanitkar, Shubangi and Makashir, Prachee and Shah, Parth and Natarajan, Sripriya and Ahmed, Sheikh Minhaj and Bagare, Prasad and Birru, Joshua and Kulkarni, Rajesh and Salunkhe, Shradha},
title = {Association of Viraemic Phase Viral Load, Antibody Responses, and Immune Biomarkers With Severe Dengue},
journal = {Journal of Medical Virology},
year = {2026},
volume = {98},
number = {4},
doi = {10.1002/jmv.70882}
}
EUVIMED